PedAM
Pediatric Disease Annotations & Medicines
| Disease | liver disease |
| Phenotype | C0011847|diabetes |
| Sentences | 70 |
| PubMedID- 22025861 | Our study revealed that silymarin has good effect in the restoration of liver function and also established efficacy in controlling blood glucose level in diabetes patients with liver diseases. |
| PubMedID- 26441826 | Management of diabetes in patients with liver diseases is, however, complicated by the effects of drug metabolism by the liver, drug interactions, and potential liver toxicity of some medications used to treat diabetes [for review, see ref. |
| PubMedID- 25120322 | The aim of our study was to evaluate the relationship of hepatic fibrosis and steatosis assessed by transient elastography with diabetes in patients with chronic liver disease. |
| PubMedID- 24952996 | Established fatty liver disease is associated with diabetes, which itself induces enteric neuron damage. |
| PubMedID- 26116622 | In addition, we describe recent findings regarding the role of fgf21 in the pathogenesis and treatment of diabetes associated with obesity, liver diseases, pancreatitis, muscle atrophy, atherosclerosis, cardiac hypertrophy, and diabetic nephropathy. |
| PubMedID- 22787177 | Despite higher susceptibility to nonalcoholic fatty liver disease in patients with type 2 diabetes, a similar alt and ast elevation was observed in a type 1 diabetes study of ly2605541 (17). |
| PubMedID- 24717062 | *non-significant elixhauser comorbidity measures across the frequency groups included peripheral vascular disease, hypertension, neurological disorders, diabetes with complications, liver disease, peptic ulcer disease, acquired immunodeficiency syndrome, lymphoma, solid tumor without metastasis, coagulopathy, fluid and electrolyte disorders, anemia, and alcohol abuse. |
| PubMedID- 24919218 | [advancement of researches on association of non-alcoholic fatty liver disease with type 2 diabetes mellitus]. |
| PubMedID- 21478462 | Prevalence of and risk factors for hepatic steatosis and nonalcoholic fatty liver disease in people with type 2 diabetes: the edinburgh type 2 diabetes study. |
| PubMedID- 24912965 | The morbidity and associated risk factors of cancer in chronic liver disease patients with diabetes mellitus: a multicenter field survey. |
| PubMedID- 26398404 | Log binomial regression models were constructed to determine predictors (age, sex, rural residence, income quintile, baseline comorbidity index value, diabetes diagnosis, indicators of severe liver disease, outpatient visits, and viral hepatitis index year) [33] of receiving ≥1 ultrasound screening annually for 2 years before hcc diagnosis. |
| PubMedID- 25966055 | Role of apn and tnf-alpha in type 2 diabetes mellitus complicated by nonalcoholic fatty liver disease. |
| PubMedID- 26381272 | Comparative efficacy of anti-diabetic agents on nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized and non-randomized studies. |
| PubMedID- 22913901 | Managing diabetes in patients with chronic liver disease. |
| PubMedID- 24669954 | Pharmacokinetic and toxicological considerations for the treatment of diabetes in patients with liver disease. |
| PubMedID- 26573192 | Objective: to investigate the effect of body mass index (bmi) on new-onset non-alcoholic fatty liver disease (nafld) in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 22927782 | The effectiveness of liraglutide in nonalcoholic fatty liver disease patients with type 2 diabetes mellitus compared to sitagliptin and pioglitazone. |
| PubMedID- 25841911 | Majority of cases of hcc are due to chronic viral hepatitis b and c infections; however non-alcoholic fatty liver disease, associated with obesity and diabetes emerges as an important risk factor for hcc, in particular in the developed countries. |
| PubMedID- 25885947 | High prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and normal plasma aminotransferase levels. |
| PubMedID- 24667697 | The cytokeratin-18 fragment level as a biomarker of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. |
| PubMedID- 20625647 | Objective: to evaluate the frequency of non-alcoholic fatty liver disease (nafld) in patients with type 2 diabetes mellitus (dm2) and to describe its risk factors. |
| PubMedID- 24485856 | As for the management of diabetes in patients with liver disease, lifestyle modification plays an important role. |
| PubMedID- 25303488 | High prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and normal plasma aminotransferase levels. |
| PubMedID- 23226654 | Introduction: non-alcoholic fatty liver disease (nafld) is associated with type 2 diabetes (t2dm) and the metabolic syndrome, and can progress to chronic liver disease. |
| PubMedID- 21596453 | Serum fgf21 levels are increased in newly diagnosed type 2 diabetes with nonalcoholic fatty liver disease and associated with hscrp levels independently. |
| PubMedID- 20736249 | In this study, we examined serum 1,5-ag levels in chronic liver disease (cld) patients with and without diabetes mellitus. |
| PubMedID- 25829790 | Background: insulin resistance (ir) is amalgam of pathologies like altered glucos metabolism, dyslipidemia, impaired glucose tolerance, non-alcoholic fatty liver disease, and associated with type-ii diabetes and cardiometabolic diseases. |
| PubMedID- 26147768 | Influence of the rs738409 polymorphism in patatin-like phospholipase 3 on the treatment efficacy of non-alcoholic fatty liver disease with type 2 diabetes mellitus. |
| PubMedID- 25877002 | The aggravation of mitochondrial dysfunction in nonalcoholic fatty liver disease accompanied with type 2 diabetes mellitus. |
| PubMedID- 21329534 | Treatment of diabetes in patients with chronic liver disease can theoretically improve survival. |
| PubMedID- 22156706 | We examined the prevalence of advanced liver disease in people with type 2 diabetes and analysed the effectiveness of liver function tests (lfts) as a screening tool. |
| PubMedID- 23869321 | Quoted that “non-alcoholic fatty liver disease is associated with type 2 diabetes and the metabolic syndrome.”[1] however, in the present report,[1] the retrospective review is done. |
| PubMedID- 26198953 | Objective: to investigate the association of serum pigment epithelium-derived factor (pedf) level and polymorphisms in pedf gene promoter region -358g-->a with non-alcoholic fatty liver disease (nafld) in patients with type 2 diabetes mellitus (t2dm) of han nationality in fujian province. |
| PubMedID- 21435130 | Efficacy and safety in sitagliptin therapy for diabetes complicated by chronic liver disease caused by hepatitis c virus. |
| PubMedID- 23043895 | Fatty liver disease is epidemiologically associated with type 2 diabetes (t2d), leading to a speculation of a reciprocal cause-effect relationship and a vicious cycle of pathology. |
| PubMedID- 25790917 | Conclusion: our investigations show that in fatty liver disease in combination with obesity and diabetes, the hepatocyte-protecting organelle peroxisome is altered. |
| PubMedID- 25457210 | Background & aims: genetic variants of patatin-like phospholipase domain-containing 3 (pnpla3) and diabetes are associated with liver disease severity, in patients with chronic hepatitis c (chc) infection. |
| PubMedID- 25820927 | Patients were excluded from the study if they had type 1 diabetes, a history of ketoacidosis, active liver disease, significant and active cardiovascular disease, malignancy, hematological disorders or hyperthyroidism. |
| PubMedID- 21850244 | Elevated ggt and gpt–values as well as estimates of fatty liver disease are significantly associated with pre-diabetes and diabetes and thus very useful first indicators of a disturbed glucose metabolism. |
| PubMedID- 23489256 | Efficacy and safety in sitagliptin therapy for diabetes complicated by non-alcoholic fatty liver disease. |
| PubMedID- 24550655 | Bpa has also been associated with chronic disease in humans including cardiovascular disease, diabetes, and serum markers of liver disease (14). |
| PubMedID- 26390278 | diabetes is associated with liver disease progression and increased hepatocellular carcinoma risk, but factors associated with diabetes in patients with chronic hepatitis b virus (hbv) infection in north america are unknown. |
| PubMedID- 25140521 | Context: both longer habitual day napping and non-alcoholic fatty liver disease (nafld) are associated with diabetes and inflammation, but the association between day napping and nafld remains unexplored. |
| PubMedID- 24587848 | The association between hcv and diabetes with liver disease severity was explored by hui et al. |
| PubMedID- 23991421 | It has been found that among men with diabetes, the risk of chronic nonalcoholic liver disease and hcc is doubled [81]. |
| PubMedID- 26339423 | Prognostic value of high sensitivity c-reaction protein in non-insulin dependent diabetes mellitus patients with non-alcoholic fatty liver disease. |
| PubMedID- 26454513 | Clinically significant chronic liver disease in people with type 2 diabetes: the edinburgh type 2 diabetes study. |
| PubMedID- 23671610 | We aim to investigate the relationships that fatty pancreas and nonalcoholic fatty liver disease (nafld) have with prediabetes and diabetes in a chinese population. |
| PubMedID- 24402015 | Exenatide improves type 2 diabetes concomitant with non-alcoholic fatty liver disease. |
| PubMedID- 26274925 | Comorbidities examined in this study included acquired immunodeficiency syndrome (aids), cardiovascular disease (cad), cerebrovascular disease (cvd), mild diabetes, diabetes with complications, liver disease, primary malignancy, metastatic malignancy, and renal disease. |
Page: 1 2